About Venaxis
Venaxis is a company based in Castle Rock (United States) founded in 2012. Venaxis has raised $1.95 million across 1 funding round. Venaxis has completed 1 acquisition, including Riot Platforms. Venaxis operates in a competitive market with competitors including Gemelli Biotech, Chosen Diagnostics, AgPlus Diagnostics, Oxford MEStar and ibs-smart, among others.
- Headquarter Castle Rock, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.95 M (USD)
in 1 rounds
-
Latest Funding Round
$1.95 M (USD), Seed
Sep 12, 2016
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Venaxis
Venaxis has successfully raised a total of $1.95M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.95 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Venaxis
Venaxis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Riot Platforms.
Investment portfolio details for Venaxis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bitcoin mining solutions are offered by the platform.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Venaxis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Venaxis
Detailed financials for Venaxis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Venaxis Comparisons
Peer comparison for Venaxis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Venaxis
Venaxis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gemelli Biotech, Chosen Diagnostics, AgPlus Diagnostics, Oxford MEStar and ibs-smart, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostics and therapeutics for the human microbiome are provided.
|
|
| Locked | Locked | Locked |
Developing a novel MDx kit to diagnose a severe bowel disorder in premature infants
|
|
| Locked | Locked | Locked |
Portable diagnostic platforms are developed using electrochemistry and nanotechnology.
|
|
| Locked | Locked | Locked |
Developer of novel scaffolds for tissue engineering and stem cell delivery
|
|
| Locked | Locked | Locked |
Develops and provides at-home blood tests for diagnosing irritable bowel syndrome.
|
Detailed competitors of Venaxis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Venaxis
Complete news archive for Venaxis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venaxis
Venaxis was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Venaxis is headquartered in Castle Rock, United States. It is registered at Castle Rock, Colorado, United States.
Steve Lundy is the current CEO of Venaxis.
Venaxis is a funded company, having raised a total of $1.95M across 1 funding round to date.
Venaxis was founded in 2012 and is based in Castle Rock, United States. Operations center on the medical diagnostics sector, where in vitro tests for appendicitis are developed. The APPY1 Test, a multi-biomarker diagnostic tool, is provided to assess patient risk for appendicitis. Leadership is held by Steve Lundy as President and CEO. The companys domain is venaxis.com.
Venaxis's top competitors include Gemelli Biotech, Chosen Diagnostics and AgPlus Diagnostics.
Venaxis has made 1 acquisition, including Riot Platforms.